IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
VIM |
P08670
|
vimentin
|
|
0.71 |
0.372 |
0.846 |
HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
CDH1 |
P12830
|
cadherin 1
|
|
0.15 |
0.401 |
0.808 |
SMN2 |
Q16637
|
survival of motor neuron 2, centromeric
|
|
0.10 |
0.459 |
0.769 |
TNFRSF11A |
Q9Y6Q6
|
TNF receptor superfamily member 11a
|
|
8.8E-03 |
0.480 |
0.846 |
MMP2 |
P08253
|
matrix metallopeptidase 2
|
Enzyme
|
0.84 |
0.333 |
0.923 |
FASN |
P49327
|
fatty acid synthase
|
Enzyme
|
1.00 |
0.474 |
0.846 |
SMN1 |
Q16637
|
survival of motor neuron 1, telomeric
|
Epigenetic regulator
|
1.6E-02 |
0.454 |
0.769 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
SRC |
P12931
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.467 |
0.885 |
NCOA1 |
Q15788
|
nuclear receptor coactivator 1
|
Kinase
|
1.00 |
0.563 |
0.731 |
AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
STAT3 |
P40763
|
signal transducer and activator of transcription 3
|
Nucleic acid binding
|
1.00 |
0.320 |
0.923 |
MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |
HMGA2 |
P52926
|
high mobility group AT-hook 2
|
Nucleic acid binding
|
0.87 |
0.429 |
0.808 |
FGF2 |
P09038
|
fibroblast growth factor 2
|
Signaling
|
1.8E-02 |
0.383 |
0.923 |
TGFA |
P01135
|
transforming growth factor alpha
|
Signaling
|
0.72 |
0.432 |
0.885 |
FGF13 |
Q92913
|
fibroblast growth factor 13
|
Signaling
|
0.89 |
0.514 |
0.808 |